Takeda and Indonesia partner on plasma-derived therapies
Takeda plans to invest up to $30m to begin establishing an ecosystem for PDMPs and a plasma donation pilot.
Drug Development
FDA approves MSD’s Keytruda combinations for MIBC
Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar
Apertura and NIH institutes to test gene therapy for NPC1
Sino and AstraZeneca sign licence agreement for TQC3721
Evogene and Tel Aviv University launch drug discovery initiative
FDA grants rare paediatric designation to Vanda’s CMT2S therapy
Biocytogen and Whitehawk partner to develop ADCs
